This filing is a routine advance notice of a small insider sell from option exercises. The consistent, pattern-based selling suggests a pre-arranged plan or tax-covering strategy. No material read-through for the stock—monitor any acceleration in selling cadence or a shift to open-market sales for real concern.
Price Chart
Executive Summary
Officer David Rodman filed Form 144 to sell 4,584 shares of Mineralys Therapeutics (MLYS) at an estimated $114,600. The sale is part of a recurring pattern of small dispositions—the insider has executed similar sales every few weeks since March 2026—and represents a negligible fraction of the $2.0B market cap.
Key Facts
- Filing date June 17, 2026; insider Rodman David Malcom is an Officer.
- Proposed sale of 4,584 shares at ~$114,600 (estimated based on market price).
- Insider has sold shares on 14 separate occasions between March 12 and June 15, 2026, all via broker-assisted cashless exercises from vested options.
- Prior sales totaled over $2M; current filing represents routine portfolio diversification, not a change in conviction.
Financial Impact
Proceeds of ~$114,600 are immaterial relative to $2.0B market cap and insider's likely position size.
Risk Factors
- Insider selling could accelerate or expand beyond the current pattern, potentially signaling reduced confidence.
- Historical MLYS reports have negative average returns at T+5/T+20, though this filing is unlikely to drive movement on its own.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000294 |
| Document: 0001964306-26-000294-index.html | 0001964306-26-000294 |
| Document: 0001964306-26-000294.txt | 0001964306-26-000294 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $23.63 (−9.43%) |
Jul 23, 2026 10w ago | Insider Cluster | $26.71 $25.65 | ▼ −3.97% | ▼ −7.59% | $23.63 (−11.53%) |
Jul 21, 2026 10w ago | Insider Cluster | $27.52 $26.61 | ▼ −3.31% | ▼ −5.87% | $23.63 (−14.14%) |
Jul 16, 2026 11w ago | Insider Cluster | $27.08 $26.09 | ▼ −3.66% | ▼ −7.27% | $23.63 (−12.74%) |
Jun 30, 2026 13w ago | 144 | $26.89 $26.35 | ▼ −2.01% | ▲ +0.18% | $23.63 (−12.12%) |
Jun 29, 2026 13w ago | 144 | $26.88 $26.71 | ▼ −0.63% | ▼ −0.35% | $23.63 (−12.09%) |
Jun 18, 2026 15w ago | Insider Cluster | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.63 (−4.06%) |
Jun 17, 2026 15w ago | 144 | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.63 (−4.06%) |
Jun 11, 2026 16w ago | Institutional Cluster | $23.94 $28.96 | ▲ +20.97% | ▲ +19.08% | $23.63 (−1.29%) |
Jun 3, 2026 17w ago | 8-K | $25.06 $27.69 | ▲ +10.49% | ▲ +11.49% | $23.63 (−5.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access